⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL5490826 | 0.95 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL4715248 | 0.91 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL6648517 | 0.80 | SMN1; SMN2 (0.46) | — | |
| SCHEMBL6852534 | 0.80 | SMN1; SMN2 (0.46) | — | |
| SCHEMBL3446639 | 0.80 | TSHR (0.36) | — | |
| SCHEMBL1555007 | 0.78 | — | — | |
| SCHEMBL12907664 | 0.76 | — | — | |
| SCHEMBL11261114 | 0.76 | HCAR2 (0.44) | — | |
| SCHEMBL2911301 | 0.76 | — | — | |
| SCHEMBL7792288 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638707-A1 | NANOFIBROUS SCAFFOLD FOR INDUSTRIAL SCALE CELL CULTURING | Cellevate AB (SE) | 2025-10-29 | — | — | EP | claimed |
| WO-2024133634-A1 | NANOFIBROUS SCAFFOLD FOR INDUSTRIAL SCALE CELL CULTURING | CELLEVATE AB (SE) | 2024-06-27 | — | — | WO | claimed |
| EP-1143970-B1 | PYRIDINE COMPOUNDS, USE AND PREPARATION THEREOF | SOUTHERN RES INST (US) | 2010-07-21 | — | — | EP | claimed |
| US-7034154-B2 | Synthesis of substituted pyrazolopyrimidines | NEUROCRINE BIOSCIENCES, INC. (US) | 2006-04-25 | — | — | US | claimed |
| US-20030236397-A1 | Process for preparing beta-L-2'deoxy-thymidine | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2003-12-25 | — | — | US | claimed |
| JP-2003506453-A | — | — | 2003-02-18 | — | — | JP | claimed |
| US-20030004346-A1 | Synthesis of substituted pyrazolopyrimidines | NEUROCRINE BIOSCIENCES, INC. (US) | 2003-01-02 | — | — | US | claimed |
| US-6472528-B1 | TREATING CONDITIONS WHICH BENEFIT FROM ADMINISTRATION OF AGENTS WHICH POSSESS ANXIOLYTIC, ANTI-ANOXIC, SLEEP-INDUCING, HYPNOTIC, ANTICONVULSANT, AND/OR SKELETAL MUSCLE RELAXANT PROPERTIES. SUCH CONDITIONS INCLUDE INSOMNIA | NEUROCRINE BIOSCIENCES, INC. | 2002-10-29 | — | — | US | claimed |
| EP-1208102-A1 | SYNTHESIS OF SUBSTITUTED PYRAZOLOPYRIMIDINES | Neurocrine Biosciences, Inc. (US) | 2002-05-29 | — | — | EP | claimed |
| WO-2001010868-A1 | SYNTHESIS OF SUBSTITUTED PYRAZOLOPYRIMIDINES | NEUROCRINE BIOSCIENCES, INC. (US) | 2001-02-15 | — | — | WO | claimed |
| US-4997955-A | From aldehyde | BASF AKTIENGESELLSCHAFT (DE) | 1991-03-05 | — | — | US | claimed |
| JP-2296801-A | — | — | None | — | — | JP | disclosed |
| EP-4638707-A1 | NANOFIBROUS SCAFFOLD FOR INDUSTRIAL SCALE CELL CULTURING | Cellevate AB (SE) | 2025-10-29 | — | — | EP | disclosed |
| EP-4619376-A2 | CYCLIC DESIGNER SCAFFOLDS FOR THE COVALENT TARGETING OF PROTEINS VIA MICHAEL ADDITION | Protenic Fejleszto Es Szolgaltato Kft. (HU) | 2025-09-24 | — | — | EP | disclosed |
| US-20240329525-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING CURED RELIEF PATTERN, AND SEMICONDUCTOR APPARATUS | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-10-03 | — | — | US | disclosed |
| US-4285959-A | CONTROLLING PHYTOPATHOGENS; NONPHYTOTOXIC | CIBA-GEIGY CORPORATION (US) | 1981-08-25 | — | — | US | disclosed |
| US-4255587-A | CARBONYLATION OF 2,6-DIALKYLANILINES USING AN OXO-SUBSTITUTED ESTER FOLLOWED BY CATALYTIC HYDROGENATION | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-10 | — | — | US | disclosed |
| EP-0023539-A1 | Alkyl esters of 3-(N-1,3,4-thiadiazolyl-2)-amino-alkyl acrylic acid, process for their preparation and their use as plant bactericides | CIBA-GEIGY AG (CH) | 1981-02-11 | — | — | EP | disclosed |
| US-4055590-A | FROM AN AMIDE AND ALCOHOL, CATALYST | ROHM GMBH (DT) | 1977-10-25 | — | — | US | disclosed |
| US-4001336-A | 2,6,10-TRIMETHYL-DODECAN-1-AL AND 2,6,10-TRIMETHYL-DODECA-4,8-DIEN-1-AL | BASF AKTIENGESELLSCHAFT (DT) | 1977-01-04 | — | — | US | disclosed |